Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs TherapeuticsMD, Inc. (TXMD)

Incannex Healthcare Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $28.1M against $20.1M — 1.4× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −6.64%) and the higher return on invested capital (0.00% vs −13.8%). Across the 16 metrics below, Incannex Healthcare Inc. leads on 8 and TherapeuticsMD, Inc. on 8.

Valuation

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.45
P/S 16.73 6.16 2.11
P/B 0.39 0.74 1.69
Price to free cash flow n/m 7.40 15.98
EV/EBITDA 1.66 n/m 12.21
EV/Sales (24.23) 84.49 2.79
Earnings yield (76.43%) (1.34%) (15.61%)
Free cash flow yield (49.31%) 13.51% 0.00%

Profitability

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 100.00% 53.51%
Operating margin 0.00% (120.89%) 0.00%
Net margin 0.00% (6.64%) (2.31%)
Free cash flow margin 0.00% 94.71% 0.00%
Return on equity (47.80%) (0.80%) (0.80%)
Return on assets (41.32%) (0.57%) (1.67%)
Return on invested capital 0.00% (13.77%) 0.00%

Growth

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 27.78% 5.22%
EPS growth (last fiscal year) 95.91% 73.68% 42.91%
Revenue growth, 5-year CAGR (29.64%) (45.84%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 48.81 3.22 2.46
Net debt to EBITDA 2.97 2.34 1.01

Dividend

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.47%
Payout ratio — — 0.28

Size

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Market cap 28.09m 20.14m 300.78m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack